NCT01923558

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

Single Dose Crossover Comparative Bioavailability Study of Donepezil 23 mg Tablets in Healthy Male and Female Volunteers / Fasting State

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 76 (actual)
• Sponsor: Dr. Reddy's Laboratories Limited · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To evaluate and compare the relative bioavailability and therefore the bioequivalence of two different formulations of donepezil after a single oral dose administration under fasting conditions.

Detailed description

Single center, randomized, single dose, laboratory-blinded, 2-period, 2-sequence, crossover study under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Donepezil	Donepezil Hydrochloride tablets,23 mg

Timeline

• Start date: 2010-10-01
• Primary completion: 2010-10-01
• Completion: 2010-11-01
• First posted: 2013-08-15
• Last updated: 2013-08-15

Locations

1 site across 1 country: Canada